NEWS

May 10, 2017

Julie McHugh Joins HealthCare Royalty Partners Strategic Advisory Board

February 20, 2017

Smaller finance firms rise to fill gaps in Stamford

February 3, 2017

Portola Pharmaceuticals Signs $150 Million Royalty Agreement with HealthCare Royalty Partners for Development and Commercialization of Andexanet Alfa

January 27, 2017

HealthCare Royalty Partners Announces New Chief Medical Officer, Senior-Level Promotions, and Further Regional Expansion

December 21, 2016

XOMA Announces up to $22 Million Generated from Sale of Royalty Streams from Two License Agreements to HealthCare Royalty Partners and Provides Corporate Update

December 12, 2016

Grünenthal to acquire commercialization rights of Qutenza® in Europe from Astellas Pharma Europe

November 7, 2016

Progenics Announces $50 Million RELISTOR® Royalty-Backed Financing

September 29, 2016

Stereotaxis Completes Private Placement of $24 Million

September 12, 2016

Horizon Pharma plc to Acquire Raptor Pharmaceutical Corp. as Further Step in Building Leading Rare Disease Business

September 9, 2016

AcuFocus Raises $66 Million in New Financing Round Led by KKR